Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed250%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer

NCT07482566
completednot_applicable

PG Versus TG for Advanced PGC

NCT06614439
recruitingnot_applicable

Laparoscopic vs Open Total Gastrectomy for Gastric Cancer

NCT05537129
completed

Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival

NCT03416101

Clinical Trials (4)

Showing 4 of 4 trials
NCT07482566Not Applicable

Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer

Recruiting
NCT06614439Not Applicable

PG Versus TG for Advanced PGC

Completed
NCT05537129Not Applicable

Laparoscopic vs Open Total Gastrectomy for Gastric Cancer

Recruiting
NCT03416101

Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4